Metabomed
Latest round
- Series B
Last raised
- Dec 2019
Total raised
- $31M
Investors
- 8
About Metabomed
Established in 2013 and based in Yavne, Israel, Metabomed is a biotechnology company that focuses on the discovery and development of potential small molecule drugs directed against novel targets in the field of cancer metabolism.
Who invested in Metabomed
8 investors across 3 rounds
See all investors in Metabomed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Metabomed
Who invested in Metabomed?
Metabomed has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Metabomed raised?
Metabomed has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Metabomed last raise money?
Metabomed's most recent round on record is a Series B, in Dec 2019.
What does Metabomed do?
Established in 2013 and based in Yavne, Israel, Metabomed is a biotechnology company that focuses on the discovery and development of potential small molecule drugs directed against novel targets in the field of cancer metabolism.
Where is Metabomed headquartered?
Metabomed is headquartered in Yavne, Israel.
Which VCs invest in companies like Metabomed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Metabomed's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Metabomed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.